COMMUNIQUÉS West-GlobeNewswire

Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH

05/03/2018 - 07:01

Pratteln, Switzerland, March 5, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the exploratory Phase I/II clinical trial in primary progressive multiple sclerosis (PPMS) conducted as an investigator- [...]

Addex Secures Investor Commitment for CHF40 million Capital Increase Following Successful Completion of Book Building Process

05/03/2018 - 07:01

Geneva, Switzerland, 5 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that the Company has secured investor commitments for [...]

Immutep receives A$686,704 R&D Tax Incentive

05/03/2018 - 04:27

SYDNEY, Australia, March 04, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”), is pleased to announce that it has received a A$686,704 cash rebate from the Australian [...]

Onconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at American Association for Cancer Research (AACR) Epigenetics Conference

04/03/2018 - 16:00

Effect of rigosertib plus azacitidine treatment on epigenetic modulation in cancer cell-lines and patient derived bone marrow cells Study suggests potential novel clinical strategies to improve outcomes for patients [...]

New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for HAE to be Presented at 2018 AAAAI/WAO Joint Congress

03/03/2018 - 15:46

New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for Hereditary Angioedema to be Presented at 2018 AAAAI/WAO Joint Congress - Data from the largest prevention study in HAE [...]

Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02/03/2018 - 22:30

BURLINGTON, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to two new employees for an aggregate of 4,000 shares of common stock [...]

Molecular Templates Closes $10 Million Debt Facility with Perceptive Advisors

02/03/2018 - 22:30

AUSTIN, Texas, March 02, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]

EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update

02/03/2018 - 22:28

WALTHAM, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage specialty pharmaceutical company that focuses on developing and [...]

Clearside Biomedical Schedules Conference Call to Review Topline Results from Pivotal Phase 3 PEACHTREE Clinical Trial of CLS-TA in Macular Edema Associated with Non-Infectious Uveitis

02/03/2018 - 22:05

ALPHARETTA, Ga., March 02, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today [...]

Recro Pharma Announces Commercial Team Additions

02/03/2018 - 22:05

MALVERN, Pa., March 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today [...]

Endocyte Announces Closing of Public Offering of Common Stock

02/03/2018 - 22:01

WEST LAFAYETTE, March 02, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, announced today the closing of an [...]

Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

02/03/2018 - 22:01

CHESTERBROOK, Pa., March 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that the independent Compensation Committee of the Board of Directors of the Company approved, effective as of February [...]

Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2017

02/03/2018 - 22:01

SANTA BARBARA, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its fourth quarter and [...]

The Delta Companies Chairman Seiki “Stan” Hirota Named to the Prestigious Staffing 100 List by Staffing Industry Analysts

02/03/2018 - 21:26

DALLAS, March 02, 2018 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading staffing firm for healthcare professionals nationwide, announced that Executive Chairman Seiki “Stan” Hirota has been named to the Staffing [...]

Celldex to Report Fourth Quarter and Year-End 2017 Business/Financial Results and Present at Upcoming Investor Conference

02/03/2018 - 21:15

HAMPTON, N.J., March 02, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq: CLDX ) announced today upcoming investor events in March. 2017 Year-End Results and Conference Call/Webcast Celldex will release [...]

Tauriga Sciences Inc. to Issue Important and Material Shareholder Update Early Next Week

02/03/2018 - 21:00

NEW YORK, NY, March 02, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]

ICU Medical, Inc. to Present at Raymond James’ 39th Annual Institutional Investors Conference

02/03/2018 - 18:51

SAN CLEMENTE, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]

RavenQuest Expands National Presence; Completes Bloomera Acquisition

02/03/2018 - 18:00

VANCOUVER, British Columbia, March 02, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) ( the "RavenQuest") is pleased to announce that it has completed the acquisition of 8649081 Canada Inc. ("Bloomera"), a [...]

Otonomy Announces FDA Approval of OTIPRIO(R) for Acute Otitis Externa

02/03/2018 - 17:55

SAN DIEGO, March 02, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced that the U.S. Food and Drug [...]